Małgorzata Słaboń
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Małgorzata Słaboń has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Kaźmierczyk
1st Military Clinical Hospital with the Outpatient Clinic, Lublin, Poland
8 shared publications - Daria Madycka
University Clinical Hospital No. 1 in Lublin, Lublin, Poland
8 shared publications - Jędrzej Kęsik
1st Military Clinical Hospital with the Outpatient Clinic, Lublin, Poland
8 shared publications - Karol Stępniak
1st Military Clinical Hospital with the Outpatient Clinic, Lublin, Poland
8 shared publications - Joanna Wrona
4th Clinical University Hospital in Lublin, ul. Kazimierza Jaczewskiego 8, 20-954 Lublin, Poland
7 shared publications - Maciej Sobczyk
Military Clinical Hospital in Lublin, al. Racławickie 23, 20-049 Lublin, Poland
7 shared publications
Latest Publications
- Open Access
- 21 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
INFECTIVE ENDOCARDITIS – THE REVIEW
Infective endocarditis (IE) is a serious and potentially life-threatening infection that affects the endocardium, heart valves, or implanted cardiac devices. It can present with a broad range of nonspecific symptoms, making early diagnosis difficult. The condition is typically confirmed through the detection of bacteremia and various imaging techniques, such as echocardiography, computed tomography (CT), and nuclear imaging. These tests can reveal anatomical changes or areas of altered metabolism, particularly on the heart valves or around foreign materials, such as prosthetic valves or cardiac devices. Treatment of IE generally involves a combination of antibiotic therapy and, in some cases, surgical intervention, with the decision for surgery depending on the patient’s evolving clinical status. Over time, the epidemiology of IE has shifted, largely due to the increasing use of prosthetic valves and implantable devices, resulting in a higher incidence among older patients with multiple comorbidities. Historically, Streptococci and Enterococci were the primary causative organisms, but recent trends show a rise in infections caused by Staphylococci species and non-HACEK organisms. The management of IE requires early recognition, tailored antibiotic therapy, and timely surgical intervention when necessary. A multidisciplinary approach involving cardiologists, infectious disease specialists, and surgeons is essential for optimal care, given the complexity and high mortality associated with the condition. This review highlights the evolving epidemiology, diagnostic approaches, and treatment strategies for IE, emphasizing the importance of early detection and coordinated care.
- 21 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Open AccessINFECTIVE ENDOCARDITIS – THE REVIEW
Infective endocarditis (IE) is a serious and potentially life-threatening infection that affects the endocardium, heart valves, or implanted cardiac devices. It can present with a broad range of nonspecific symptoms, making early diagnosis difficult. The condition is typically confirmed through the detection of bacteremia and various imaging techniques, such as echocardiography, computed tomography (CT), and nuclear imaging. These tests can reveal anatomical changes or areas of altered metabolism, particularly on the heart valves or around foreign materials, such as prosthetic valves or cardiac devices. Treatment of IE generally involves a combination of antibiotic therapy and, in some cases, surgical intervention, with the decision for surgery depending on the patient’s evolving clinical status. Over time, the epidemiology of IE has shifted, largely due to the increasing use of prosthetic valves and implantable devices, resulting in a higher incidence among older patients with multiple comorbidities. Historically, Streptococci and Enterococci were the primary causative organisms, but recent trends show a rise in infections caused by Staphylococci species and non-HACEK organisms. The management of IE requires early recognition, tailored antibiotic therapy, and timely surgical intervention when necessary. A multidisciplinary approach involving cardiologists, infectious disease specialists, and surgeons is essential for optimal care, given the complexity and high mortality associated with the condition. This review highlights the evolving epidemiology, diagnostic approaches, and treatment strategies for IE, emphasizing the importance of early detection and coordinated care.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
MANAGEMENT OF ACUTE LIMB ISCHEMIA - THE REVIEW
Acute limb ischemia (ALI) is a sudden reduction in limb perfusion that threatens limb viability and requires urgent intervention. It can present as an acute manifestation of peripheral arterial disease (PAD) or as an acute event in previously asymptomatic patients. This review outlines the epidemiology, pathophysiology, clinical features, diagnostic approaches, and current treatment strategies for ALI. Emphasis is placed on differentiating thrombotic and embolic causes, the use of imaging modalities such as CT angiography and duplex ultrasonography, and the application of the Rutherford classification to guide treatment decisions. Immediate systemic anticoagulation remains the cornerstone of early management, followed by either surgical revascularization or endovascular therapies. While open surgery remains standard in many cases, newer percutaneous mechanical thrombectomy systems (PMT) have emerged as effective alternatives, particularly in patients with contraindications to surgery or thrombolysis. Despite advances in diagnosis and therapy, ALI continues to carry a high risk of amputation and mortality.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
Open AccessMANAGEMENT OF ACUTE LIMB ISCHEMIA - THE REVIEW
Acute limb ischemia (ALI) is a sudden reduction in limb perfusion that threatens limb viability and requires urgent intervention. It can present as an acute manifestation of peripheral arterial disease (PAD) or as an acute event in previously asymptomatic patients. This review outlines the epidemiology, pathophysiology, clinical features, diagnostic approaches, and current treatment strategies for ALI. Emphasis is placed on differentiating thrombotic and embolic causes, the use of imaging modalities such as CT angiography and duplex ultrasonography, and the application of the Rutherford classification to guide treatment decisions. Immediate systemic anticoagulation remains the cornerstone of early management, followed by either surgical revascularization or endovascular therapies. While open surgery remains standard in many cases, newer percutaneous mechanical thrombectomy systems (PMT) have emerged as effective alternatives, particularly in patients with contraindications to surgery or thrombolysis. Despite advances in diagnosis and therapy, ALI continues to carry a high risk of amputation and mortality.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
OBSTRUCTIVE SLEEP APNEA AND ITS IMPACT ON ATHLETES AND SPORTS PERFORMANCE – THE REVIEW
Obstructive sleep apnea (OSA) is a prevalent and underdiagnosed condition with significant systemic health implications. It is characterized by recurrent upper airway collapse during sleep, leading to intermittent hypoxia, sleep fragmentation, and an array of comorbidities. Among the risk factors, obesity is the most common, but other factors such as sex, age, tonsillar hypertrophy, and the presence of comorbid conditions also play a role. Untreated obstructive sleep apnea (OSA) can lead to cardiovascular diseases, diabetes, strokes, and even sudden death. Diagnosis is based on medical history, clinical examination, and most importantly, polysomnographic testing. Treatment includes lifestyle modifications, continuous positive airway pressure (CPAP) therapy, and in some cases, surgical interventions. This literature review synthesizes current evidence regarding the pathophysiology, clinical presentation, diagnostic approaches, and therapeutic options for OSA in adults.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
Open AccessOBSTRUCTIVE SLEEP APNEA AND ITS IMPACT ON ATHLETES AND SPORTS PERFORMANCE – THE REVIEW
Obstructive sleep apnea (OSA) is a prevalent and underdiagnosed condition with significant systemic health implications. It is characterized by recurrent upper airway collapse during sleep, leading to intermittent hypoxia, sleep fragmentation, and an array of comorbidities. Among the risk factors, obesity is the most common, but other factors such as sex, age, tonsillar hypertrophy, and the presence of comorbid conditions also play a role. Untreated obstructive sleep apnea (OSA) can lead to cardiovascular diseases, diabetes, strokes, and even sudden death. Diagnosis is based on medical history, clinical examination, and most importantly, polysomnographic testing. Treatment includes lifestyle modifications, continuous positive airway pressure (CPAP) therapy, and in some cases, surgical interventions. This literature review synthesizes current evidence regarding the pathophysiology, clinical presentation, diagnostic approaches, and therapeutic options for OSA in adults.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
LESCH – NYHAN SYNDROME (LNS) - THE REVIEW
Lesch-Nyhan syndrome (LNS) is a rare X-linked disorder caused by mutations in the HPRT1 gene, which encodes an important enzyme in the purine salvage pathway. Symptoms of LNS include dystonia, gout, intellectual disability, and self-harm. Although the disease was described in 1964, it remains unclear how abnormalities in hypoxanthine and guanine recycling can lead to such significant neurological deficits. Several studies have proposed different hypotheses regarding the etiology of the disease and various treatment options have been proposed, but none have led to a satisfactory explanation of the pathophysiology of the disease. New technologies such as sequencing, optogenetics, genome editing, and induced pluripotent stem cells may provide a unique opportunity to map the precise sequential pathways from genotype to disease phenotype.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
Open AccessLESCH – NYHAN SYNDROME (LNS) - THE REVIEW
Lesch-Nyhan syndrome (LNS) is a rare X-linked disorder caused by mutations in the HPRT1 gene, which encodes an important enzyme in the purine salvage pathway. Symptoms of LNS include dystonia, gout, intellectual disability, and self-harm. Although the disease was described in 1964, it remains unclear how abnormalities in hypoxanthine and guanine recycling can lead to such significant neurological deficits. Several studies have proposed different hypotheses regarding the etiology of the disease and various treatment options have been proposed, but none have led to a satisfactory explanation of the pathophysiology of the disease. New technologies such as sequencing, optogenetics, genome editing, and induced pluripotent stem cells may provide a unique opportunity to map the precise sequential pathways from genotype to disease phenotype.
- Open Access
- 29 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
FROM CHRONIC SINUSITIS TO SINONASAL TUMORS: THE EXPANDING ROLE OF FESS IN MODERN SURGERY
Objective: The objective of this study was to explore the evolving role of Functional Endoscopic Sinus Surgery (FESS) - the gold standard in the treatment of chronic rhinosinusitis and other sinus diseases. Advances in diagnostic imaging, surgical instruments, and navigation systems have significantly improved the safety and efficacy of this technique. This study provides an overview of the FESS technique, and its expanding indications - application in the treatment of selected sinus tumors, such as inverted papilloma, juvenile nasopharyngeal angiofibroma (JNA), and osteomas. Methods: A narrative review of the literature was conducted, focusing on the development of FESS, its surgical technique, safety profile, and clinical outcomes. Special attention was given to its comparison with traditional open approaches in both inflammatory and neoplastic conditions of the sinonasal tract. Key Findings: The analysis revealed that technological progress - particularly in diagnostic imaging, surgical instruments, and intraoperative navigation - has significantly improved the precision and safety of FESS. Clinical evidence demonstrates that endoscopic resection of sinonasal tumors often achieves recurrence rates equal to or lower than those associated with open surgery, while minimizing morbidity, hospitalization time, and facial disfigurement. Successful outcomes depend on appropriate patient selection, meticulous preoperative planning, and the surgeon’s expertise. Conclusions: Functional Endoscopic Sinus Surgery is a safe and effective modality for treating a wide range of sinonasal diseases, including chronic rhinosinusitis and selected benign tumors. With proper patient selection, preoperative planning, and surgical expertise, FESS offers substantial benefits over traditional open approaches, including reduced morbidity and improved recovery. Continued technological advancements and long-term outcome studies will further refine its role in comprehensive sinonasal care.
- 29 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
Open AccessFROM CHRONIC SINUSITIS TO SINONASAL TUMORS: THE EXPANDING ROLE OF FESS IN MODERN SURGERY
Objective: The objective of this study was to explore the evolving role of Functional Endoscopic Sinus Surgery (FESS) - the gold standard in the treatment of chronic rhinosinusitis and other sinus diseases. Advances in diagnostic imaging, surgical instruments, and navigation systems have significantly improved the safety and efficacy of this technique. This study provides an overview of the FESS technique, and its expanding indications - application in the treatment of selected sinus tumors, such as inverted papilloma, juvenile nasopharyngeal angiofibroma (JNA), and osteomas. Methods: A narrative review of the literature was conducted, focusing on the development of FESS, its surgical technique, safety profile, and clinical outcomes. Special attention was given to its comparison with traditional open approaches in both inflammatory and neoplastic conditions of the sinonasal tract. Key Findings: The analysis revealed that technological progress - particularly in diagnostic imaging, surgical instruments, and intraoperative navigation - has significantly improved the precision and safety of FESS. Clinical evidence demonstrates that endoscopic resection of sinonasal tumors often achieves recurrence rates equal to or lower than those associated with open surgery, while minimizing morbidity, hospitalization time, and facial disfigurement. Successful outcomes depend on appropriate patient selection, meticulous preoperative planning, and the surgeon’s expertise. Conclusions: Functional Endoscopic Sinus Surgery is a safe and effective modality for treating a wide range of sinonasal diseases, including chronic rhinosinusitis and selected benign tumors. With proper patient selection, preoperative planning, and surgical expertise, FESS offers substantial benefits over traditional open approaches, including reduced morbidity and improved recovery. Continued technological advancements and long-term outcome studies will further refine its role in comprehensive sinonasal care.
- Open Access
- 19 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
THE USE OF BOTULINUM TOXIN AND ITS ROLE IN PAIN MANAGEMENT- A SYSTEMATIC REVIEW
Introduction and Purpose: For many decades, botulinum toxin has been used in various fields of medicine, from aesthetic procedures to urology and neurology. It has become a highly effective and important therapeutic tool in the hands of a qualified physician. The aim of this article is to provide an overview of current research on the use of botulinum toxin in medicine, with a particular focus on its role in the treatment of various types of pain. Materials and Methods: A literature review was conducted using the PubMed and Google Scholar databases. Relevant keywords were used as search terms. Conclusion: Botulinum toxin, a neurotoxin with a good safety profile, is used in numerous branches of medicine and plays an increasingly important role in the treatment of various pain conditions. This review presents the current state of knowledge on the mechanism of action and analgesic properties of botulinum toxin and highlights its promising potential in the development of new therapeutic methods.
- 19 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
Open AccessTHE USE OF BOTULINUM TOXIN AND ITS ROLE IN PAIN MANAGEMENT- A SYSTEMATIC REVIEW
Introduction and Purpose: For many decades, botulinum toxin has been used in various fields of medicine, from aesthetic procedures to urology and neurology. It has become a highly effective and important therapeutic tool in the hands of a qualified physician. The aim of this article is to provide an overview of current research on the use of botulinum toxin in medicine, with a particular focus on its role in the treatment of various types of pain. Materials and Methods: A literature review was conducted using the PubMed and Google Scholar databases. Relevant keywords were used as search terms. Conclusion: Botulinum toxin, a neurotoxin with a good safety profile, is used in numerous branches of medicine and plays an increasingly important role in the treatment of various pain conditions. This review presents the current state of knowledge on the mechanism of action and analgesic properties of botulinum toxin and highlights its promising potential in the development of new therapeutic methods.
- Open Access
- 3 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 56851
Atopic dermatitis - the review
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by a disrupted epidermal barrier, immune dysregulation, and genetic predisposition. Affecting individuals across all age groups, AD presents with recurrent flare-ups and varying clinical patterns depending on age. The pathophysiology involves key elements such as loss-of-function mutations in the filaggrin (FLG) gene, overproduction of cytokines like IL-4 and IL-13, and skin colonization by Staphylococcus aureus. Management strategies include patient education, topical therapies (e.g., corticosteroids, calcineurin inhibitors, crisaborole, and tapinarof), systemic treatments like dupilumab and methotrexate, and phototherapy for refractory cases. Preventive measures, including breastfeeding and probiotic supplementation, offer limited benefits, emphasizing the need for individualized approaches. Innovative therapies and further research into AD pathogenesis hold promise for more effective disease control and improved quality of life for patients.
- 3 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 56851
Open AccessAtopic dermatitis - the review
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by a disrupted epidermal barrier, immune dysregulation, and genetic predisposition. Affecting individuals across all age groups, AD presents with recurrent flare-ups and varying clinical patterns depending on age. The pathophysiology involves key elements such as loss-of-function mutations in the filaggrin (FLG) gene, overproduction of cytokines like IL-4 and IL-13, and skin colonization by Staphylococcus aureus. Management strategies include patient education, topical therapies (e.g., corticosteroids, calcineurin inhibitors, crisaborole, and tapinarof), systemic treatments like dupilumab and methotrexate, and phototherapy for refractory cases. Preventive measures, including breastfeeding and probiotic supplementation, offer limited benefits, emphasizing the need for individualized approaches. Innovative therapies and further research into AD pathogenesis hold promise for more effective disease control and improved quality of life for patients.
- Open Access
- 23 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 34, 56187
Deep vein thrombosis - the review
Deep vein thrombosis impacts between 2.5% and 5% of a population. It mostly affects lower-extremity veins and presents itself as pain, swelling, tenderness, and erythema of an affected region. Thrombus forms when at least one factor from the Virchow's triad is present - vascular damage, venous stasis or hypercoagulability. A range of clinical manifestations is very wide, from asymptomatic to life-threatening course of the disease. Post-thrombotic syndrome is a frequent complication that results in venous hypertension, which leads to tissue edema, subcutaneous fibrosis, and subsequent ulceration. In the diagnostic process, predominantly D-dimer assay and ultrasonographic compression test are performed. Noninvasive treatment relies on anticoagulation therapy which is based on direct oral anticoagulants, parenteral anticoagulants, and vitamin K antagonists. In specific cases, there is an option of invasive treatment, which involves inserting a catheter into a vein with a thrombus. Afterward, a thrombus can be mechanically fragmented and aspired or dissolved with the use of a thrombolytic agent.
- 23 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 34, 56187
Open AccessDeep vein thrombosis - the review
Deep vein thrombosis impacts between 2.5% and 5% of a population. It mostly affects lower-extremity veins and presents itself as pain, swelling, tenderness, and erythema of an affected region. Thrombus forms when at least one factor from the Virchow's triad is present - vascular damage, venous stasis or hypercoagulability. A range of clinical manifestations is very wide, from asymptomatic to life-threatening course of the disease. Post-thrombotic syndrome is a frequent complication that results in venous hypertension, which leads to tissue edema, subcutaneous fibrosis, and subsequent ulceration. In the diagnostic process, predominantly D-dimer assay and ultrasonographic compression test are performed. Noninvasive treatment relies on anticoagulation therapy which is based on direct oral anticoagulants, parenteral anticoagulants, and vitamin K antagonists. In specific cases, there is an option of invasive treatment, which involves inserting a catheter into a vein with a thrombus. Afterward, a thrombus can be mechanically fragmented and aspired or dissolved with the use of a thrombolytic agent.
- Open Access
- 17 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 33, 55164
Interrelationships between affective disorders in the form of depression and obesity and overweight - A systematic review
Both depression and obesity are significant health, social and economic problems. Depressive disorders were the second most common psychiatric disorder in 2017 after anxiety disorders. According to data published by the World Health Organization (WHO), depression affects about 280 million people worldwide, which is about 3.8 percent of the population. The etiology of depressive disorders is very complex and still not fully understood. The theories described so far complement each other. The factors underlying the development of depressive disorders can be divided into biological, psychological and other factors. Eating disorders in the form of overweight and obesity result from a loss of balance between anabolic and catabolic processes. This is most often led by insufficient physical activity and excess caloric intake. Hormonal disorders, genetic factors and environmental factors may also play an important role in the pathogenesis of obesity. The steadily increasing number of people suffering from depression and obesity prompts the search for links between these two seemingly unrelated disease entities. According to current knowledge, these diseases are bi-directionally linked by genetic, psychological, metabolic and social factors. Depression is associated with an increase in the risk of obesity by about 37% relative to those without depression. Obesity is associated with an increase in the risk of depressive disorders by about 18%. Understanding the links that exist between depressive disorders and obesity enables the search for new therapeutic options. The most important conclusion from the scientific research conducted so far is the advantage of simultaneous treatment of obesity and depression over treating these disease entities individually.
- 17 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 33, 55164
Open AccessInterrelationships between affective disorders in the form of depression and obesity and overweight - A systematic review
Both depression and obesity are significant health, social and economic problems. Depressive disorders were the second most common psychiatric disorder in 2017 after anxiety disorders. According to data published by the World Health Organization (WHO), depression affects about 280 million people worldwide, which is about 3.8 percent of the population. The etiology of depressive disorders is very complex and still not fully understood. The theories described so far complement each other. The factors underlying the development of depressive disorders can be divided into biological, psychological and other factors. Eating disorders in the form of overweight and obesity result from a loss of balance between anabolic and catabolic processes. This is most often led by insufficient physical activity and excess caloric intake. Hormonal disorders, genetic factors and environmental factors may also play an important role in the pathogenesis of obesity. The steadily increasing number of people suffering from depression and obesity prompts the search for links between these two seemingly unrelated disease entities. According to current knowledge, these diseases are bi-directionally linked by genetic, psychological, metabolic and social factors. Depression is associated with an increase in the risk of obesity by about 37% relative to those without depression. Obesity is associated with an increase in the risk of depressive disorders by about 18%. Understanding the links that exist between depressive disorders and obesity enables the search for new therapeutic options. The most important conclusion from the scientific research conducted so far is the advantage of simultaneous treatment of obesity and depression over treating these disease entities individually.
- Open Access
- 17 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 31, 55297
role of lipoprotein a in cardiac risk stratification and evaluation of hypolipemizing treatment
Introduction and purpose Cardiovascular diseases are one of the most common causes of death. Due to their popularity and the costs they generate, they are a significant problem. One of the cardiovascular risk factors is the level of lipoprotein(a). Lipoprotein (a) levels are not commonly used to stratify cardiovascular risk, but recommendations suggest that every adult should have them checked. The aim of this study is to discuss current knowledge about the role of lipoprotein (a) in cardiac risk stratification and evaluation of hypolipemizing treatment. Material and methods The PubMed database was used to review the literature. An electronic literature search was conducted, publication years were limited to 2018-2024. Three articles that did not meet this criterion due to their earlier publication dates were included because they served as important sources of information for this article. Keywords were used as search terms. Conclusion Based on the available data, the benefits of lowering lipoprotein(a) levels in the context of cardiovascular diseases cannot be confirmed. There is a need for further research into the role of lipoprotein (a) in stratifying cardiovascular risk, the benefits of lowering its levels, and specific therapeutic approaches for this disorder.
- 17 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 31, 55297
Open Accessrole of lipoprotein a in cardiac risk stratification and evaluation of hypolipemizing treatment
Introduction and purpose Cardiovascular diseases are one of the most common causes of death. Due to their popularity and the costs they generate, they are a significant problem. One of the cardiovascular risk factors is the level of lipoprotein(a). Lipoprotein (a) levels are not commonly used to stratify cardiovascular risk, but recommendations suggest that every adult should have them checked. The aim of this study is to discuss current knowledge about the role of lipoprotein (a) in cardiac risk stratification and evaluation of hypolipemizing treatment. Material and methods The PubMed database was used to review the literature. An electronic literature search was conducted, publication years were limited to 2018-2024. Three articles that did not meet this criterion due to their earlier publication dates were included because they served as important sources of information for this article. Keywords were used as search terms. Conclusion Based on the available data, the benefits of lowering lipoprotein(a) levels in the context of cardiovascular diseases cannot be confirmed. There is a need for further research into the role of lipoprotein (a) in stratifying cardiovascular risk, the benefits of lowering its levels, and specific therapeutic approaches for this disorder.